Effects of Roflumilast in Hospitalized COPD on Mortality and Re-hospitalization
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2017
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 10 Oct 2017 Planned End Date changed from 1 Aug 2017 to 1 Dec 2017.
- 10 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Nov 2017.
- 10 Oct 2017 Status changed from recruiting to active, no longer recruiting.